Somni-TR

Sanesco SomniTR is a delayed-released formula, designed to release 1 mg of Melatonin initially and 1 mg three hours later, to help promote the ability to stay asleep. Key Benefits: Supports Melatonin production and levels through multiple steps in the Serotonin-to-Melatonin pathway, and also influences inhibitory GABAergic activity. Melatonin in SomniTR is delayed-released to provide sustained levels for up to eight hours. Besides melatonin, SomniTR combines support for GABA-A receptor sites. GABA-A agonists have shown to improve quality of sleep. Other ingredients are added to the formula to support melatonin synthesis.